Improving Information to Caregivers Via Adaptation and Implementation of the HERMES Intervention
NCT ID: NCT04437563
Last Updated: 2022-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
1500 participants
INTERVENTIONAL
2021-02-01
2022-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Therefore, the present project will adapt the HERMES intervention to be implemented in Danish departments of oncology and haematology by (in the first part of the project):
1. Elucidating how the HERMES intervention is best implemented in the clinical setting according to the clinical staff.
2. Elucidating how the HERMES intervention is best implemented in the treatment and follow-up period according to the patients and their caregivers.
3. Developing a technological solution (an app) for the HERMES intervention in which the responses given by the caregivers will form the basis for a subsequent consultation with the health care staff.
4. Revising the HERMES intervention based on the outcomes of a-c.
5. Testing the revised HERMES intervention in a pilot study.
In the second part of the project, the revised HERMES intervention will be tested in a large scale trial with the purpose to:
1. Implement the revised HERMES intervention in the departments of oncology/haematology.
2. Test the effect of the revised HERMES intervention.
3. Evaluate the feasibility of the revised HERMES intervention in a large scale.
4. Elucidate the effectiveness and the feasibility of the intervention and assess possibilities and potential needs for further adaptation in order to secure the future applicability in the Danish Health Care System.
Thus, the overall aim is that by the end of the study, an evidence based and practical implementable method to (continous) use of the HERMES intervention in the Danish health care system is available.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improvement of Information to Cancer Patients' Caregivers
NCT02380469
The GP's Role in Cancer Rehabilitation: a Randomised, Controlled Study.
NCT01021371
Patient Empowerment and Risk-assessed Treatment to Improve Outcome in the Elderly After Onco-surgery
NCT01278537
"Resilient Caregivers" - A Resilience-based Intervention for Distressed Partner Cancer Caregivers
NCT04610034
Rehabilitation of Cancer Survivors in Denmark: The Effect of a Psychosocial Rehabilitation Course
NCT01086683
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
('Standard' care). No intervention offered.
No interventions assigned to this group
Intervention
('Standard' care +) The 'Herlev Hospital Empowerment of Relatives through More and Earlier information Supply' (HERMES) intervention.
HERMES
Via an app, the caregiver answers 14 questions about his/her need for (more) information. The caregiver presents his/her answers (i.e., need for information) to the health care professionals (HCPs), and the HCPs provide the caregiver with the lacking information.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HERMES
Via an app, the caregiver answers 14 questions about his/her need for (more) information. The caregiver presents his/her answers (i.e., need for information) to the health care professionals (HCPs), and the HCPs provide the caregiver with the lacking information.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Primary caregiver (defined as the lay person (partner, family member, friend, etc) most involved in the patient's disease course. The primary caregiver is appointed by the patient)
* Caregiver of an adult cancer patient starting up a treatment course in an oncological department
* Written informed consent to participation
Exclusion Criteria
* Caregivers with no or minimal contact to the oncological department
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Herlev Gentofte University Hospital, Denmark
UNKNOWN
Rigshospitalet, University of Copenhagen, Denmark
UNKNOWN
South Jutland Hospital, Denmark
UNKNOWN
Bispebjerg Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mogens Groenvold
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mogens Groenvold, PhD DMSc
Role: PRINCIPAL_INVESTIGATOR
Bispebjerg and Frederiksberg Hospital, University of Copenhagen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aalborg Universitetshospital
Aalborg, , Denmark
Rigshospitalet
Copenhagen, , Denmark
Herlev Hospital
Herlev, , Denmark
Hospitalsenheden Vest
Herning, , Denmark
Naestved Sygehus
Næstved, , Denmark
Roskilde Universitetshospital
Roskilde, , Denmark
Sygehus Soenderjylland
Sønderborg, , Denmark
Vejle Sygehus
Vejle, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R210-A12901
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.